tm
Seeing Is Believing
tm
Seeing Is Believing
EYPT is currently covered by 5 analysts with an average price target of $32.5. This is a potential upside of $17.48 (153.31%) from yesterday's end of day stock price of $12.83.
Eyepoint Pharmaceuticals's activity chart (see below) currently has 58 price targets and 62 ratings on display. The stock rating distribution of EYPT is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 30.96% with an average time for these price targets to be met of 266.4 days.
Highest price target for EYPT is $37, Lowest price target is $27, average price target is $32.5.
Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 06-Aug-2026. First documented stock forecast 01-Oct-2018.
Currently out of the existing stock ratings of EYPT, 10 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Nov-2021
$27
$14.17 (110.44%)
$30
Buy Since 17-Jun-2025
$37
$24.17 (188.39%)
$39
Buy Since 07-Jan-2025
$35
$22.17 (172.80%)
$33
Buy Since 07-Jul-2022
$29
$16.17 (126.03%)
$27
Buy Since 02-Nov-2023
$33
$20.17 (157.21%)
$28
What is EYPT (Eyepoint Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on EYPT (Eyepoint Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on EYPT (Eyepoint Pharmaceuticals)?
Which analyst is the currently most bullish on EYPT (Eyepoint Pharmaceuticals)?
Which analyst is the currently most reserved on EYPT (Eyepoint Pharmaceuticals)?
